nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—CYP3A4—Thiotepa—sarcoma	0.112	0.351	CbGbCtD
Repaglinide—CYP2C8—Etoposide—sarcoma	0.0747	0.235	CbGbCtD
Repaglinide—CYP3A4—Mitoxantrone—sarcoma	0.048	0.151	CbGbCtD
Repaglinide—PPARG—dermis—sarcoma	0.0331	0.107	CbGeAlD
Repaglinide—CYP3A4—Vincristine—sarcoma	0.033	0.104	CbGbCtD
Repaglinide—CYP3A4—Etoposide—sarcoma	0.0303	0.0951	CbGbCtD
Repaglinide—PPARG—periosteum—sarcoma	0.0274	0.0886	CbGeAlD
Repaglinide—PPARG—leg—sarcoma	0.0218	0.0706	CbGeAlD
Repaglinide—PPARG—forelimb—sarcoma	0.0217	0.0701	CbGeAlD
Repaglinide—CYP3A4—Doxorubicin—sarcoma	0.0207	0.0649	CbGbCtD
Repaglinide—PPARG—hindlimb—sarcoma	0.0195	0.063	CbGeAlD
Repaglinide—PPARG—appendage—sarcoma	0.0167	0.0541	CbGeAlD
Repaglinide—PPARG—Teniposide—Etoposide—sarcoma	0.0145	1	CbGdCrCtD
Repaglinide—KCNJ11—mammary gland—sarcoma	0.0116	0.0374	CbGeAlD
Repaglinide—ABCC8—mammary gland—sarcoma	0.0107	0.0345	CbGeAlD
Repaglinide—PPARG—endothelium—sarcoma	0.0101	0.0326	CbGeAlD
Repaglinide—SLCO1B1—mammary gland—sarcoma	0.00944	0.0305	CbGeAlD
Repaglinide—PPARG—mammary gland—sarcoma	0.00814	0.0263	CbGeAlD
Repaglinide—ALB—mammary gland—sarcoma	0.00764	0.0247	CbGeAlD
Repaglinide—KCNJ11—hematopoietic system—sarcoma	0.00705	0.0228	CbGeAlD
Repaglinide—ABCC8—seminal vesicle—sarcoma	0.00684	0.0221	CbGeAlD
Repaglinide—SLCO1B1—hematopoietic system—sarcoma	0.00575	0.0186	CbGeAlD
Repaglinide—ABCC8—smooth muscle tissue—sarcoma	0.00572	0.0185	CbGeAlD
Repaglinide—PPARG—embryo—sarcoma	0.00556	0.018	CbGeAlD
Repaglinide—CYP2C8—mammary gland—sarcoma	0.00537	0.0173	CbGeAlD
Repaglinide—KCNJ11—lymphoid tissue—sarcoma	0.00497	0.0161	CbGeAlD
Repaglinide—PPARG—hematopoietic system—sarcoma	0.00496	0.016	CbGeAlD
Repaglinide—PPARG—connective tissue—sarcoma	0.00478	0.0154	CbGeAlD
Repaglinide—KCNJ11—tendon—sarcoma	0.00467	0.0151	CbGeAlD
Repaglinide—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00463	0.0129	CcSEcCtD
Repaglinide—PPARG—smooth muscle tissue—sarcoma	0.00437	0.0141	CbGeAlD
Repaglinide—PPARG—skin of body—sarcoma	0.00431	0.0139	CbGeAlD
Repaglinide—Cardiovascular disorder—Etoposide—sarcoma	0.00415	0.0116	CcSEcCtD
Repaglinide—PPARG—uterus—sarcoma	0.00375	0.0121	CbGeAlD
Repaglinide—ABCC8—testis—sarcoma	0.00356	0.0115	CbGeAlD
Repaglinide—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00351	0.0098	CcSEcCtD
Repaglinide—PPARG—lymphoid tissue—sarcoma	0.00349	0.0113	CbGeAlD
Repaglinide—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00329	0.00918	CcSEcCtD
Repaglinide—PPARG—tendon—sarcoma	0.00328	0.0106	CbGeAlD
Repaglinide—CYP2C8—hematopoietic system—sarcoma	0.00327	0.0106	CbGeAlD
Repaglinide—PPARG—bone marrow—sarcoma	0.00318	0.0103	CbGeAlD
Repaglinide—SLCO1B1—liver—sarcoma	0.00298	0.00963	CbGeAlD
Repaglinide—Cardiac failure congestive—Etoposide—sarcoma	0.00292	0.00815	CcSEcCtD
Repaglinide—Hyperglycaemia—Thiotepa—sarcoma	0.00287	0.00802	CcSEcCtD
Repaglinide—KCNJ11—lymph node—sarcoma	0.0028	0.00906	CbGeAlD
Repaglinide—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00279	0.0078	CcSEcCtD
Repaglinide—Jaundice—Thiotepa—sarcoma	0.00277	0.00773	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Etoposide—sarcoma	0.00273	0.00764	CcSEcCtD
Repaglinide—PPARG—testis—sarcoma	0.00272	0.00879	CbGeAlD
Repaglinide—Hepatobiliary disease—Thiotepa—sarcoma	0.00268	0.0075	CcSEcCtD
Repaglinide—PPARG—liver—sarcoma	0.00257	0.00831	CbGeAlD
Repaglinide—ALB—testis—sarcoma	0.00255	0.00824	CbGeAlD
Repaglinide—Hepatitis—Dactinomycin—sarcoma	0.00253	0.00707	CcSEcCtD
Repaglinide—Acute coronary syndrome—Vincristine—sarcoma	0.00248	0.00693	CcSEcCtD
Repaglinide—Hyperglycaemia—Mitoxantrone—sarcoma	0.00248	0.00693	CcSEcCtD
Repaglinide—Myocardial infarction—Vincristine—sarcoma	0.00247	0.00689	CcSEcCtD
Repaglinide—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00242	0.00675	CcSEcCtD
Repaglinide—ALB—liver—sarcoma	0.00241	0.00779	CbGeAlD
Repaglinide—Myocardial infarction—Mitoxantrone—sarcoma	0.0024	0.00671	CcSEcCtD
Repaglinide—Erythema multiforme—Dactinomycin—sarcoma	0.00239	0.00668	CcSEcCtD
Repaglinide—Jaundice—Mitoxantrone—sarcoma	0.00239	0.00668	CcSEcCtD
Repaglinide—Urinary tract infection—Mitoxantrone—sarcoma	0.00238	0.00666	CcSEcCtD
Repaglinide—Eye disorder—Thiotepa—sarcoma	0.00238	0.00665	CcSEcCtD
Repaglinide—Cardiac disorder—Thiotepa—sarcoma	0.00236	0.00661	CcSEcCtD
Repaglinide—Cardiovascular disorder—Epirubicin—sarcoma	0.00232	0.0065	CcSEcCtD
Repaglinide—Immune system disorder—Thiotepa—sarcoma	0.0023	0.00643	CcSEcCtD
Repaglinide—Sinusitis—Mitoxantrone—sarcoma	0.0023	0.00643	CcSEcCtD
Repaglinide—Arrhythmia—Thiotepa—sarcoma	0.00228	0.00636	CcSEcCtD
Repaglinide—Alopecia—Thiotepa—sarcoma	0.00225	0.00629	CcSEcCtD
Repaglinide—Alopecia—Dactinomycin—sarcoma	0.00223	0.00624	CcSEcCtD
Repaglinide—Erythema—Thiotepa—sarcoma	0.00222	0.0062	CcSEcCtD
Repaglinide—Malnutrition—Thiotepa—sarcoma	0.00222	0.0062	CcSEcCtD
Repaglinide—CYP3A4—hematopoietic system—sarcoma	0.00221	0.00716	CbGeAlD
Repaglinide—Rhinitis—Mitoxantrone—sarcoma	0.00221	0.00616	CcSEcCtD
Repaglinide—Erythema—Dactinomycin—sarcoma	0.0022	0.00615	CcSEcCtD
Repaglinide—Hepatitis—Mitoxantrone—sarcoma	0.0022	0.00615	CcSEcCtD
Repaglinide—Cardiovascular disorder—Doxorubicin—sarcoma	0.00215	0.00601	CcSEcCtD
Repaglinide—Back pain—Thiotepa—sarcoma	0.00215	0.006	CcSEcCtD
Repaglinide—Cardiac disorder—Vincristine—sarcoma	0.0021	0.00586	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00202	0.00565	CcSEcCtD
Repaglinide—Acute coronary syndrome—Etoposide—sarcoma	0.00201	0.00562	CcSEcCtD
Repaglinide—Myocardial infarction—Etoposide—sarcoma	0.002	0.00558	CcSEcCtD
Repaglinide—Alopecia—Vincristine—sarcoma	0.002	0.00558	CcSEcCtD
Repaglinide—Jaundice—Etoposide—sarcoma	0.00199	0.00555	CcSEcCtD
Repaglinide—Leukopenia—Thiotepa—sarcoma	0.00199	0.00555	CcSEcCtD
Repaglinide—Leukopenia—Dactinomycin—sarcoma	0.00197	0.00551	CcSEcCtD
Repaglinide—PPARG—lymph node—sarcoma	0.00197	0.00637	CbGeAlD
Repaglinide—Arrhythmia—Mitoxantrone—sarcoma	0.00197	0.00549	CcSEcCtD
Repaglinide—Alopecia—Mitoxantrone—sarcoma	0.00194	0.00543	CcSEcCtD
Repaglinide—Hepatobiliary disease—Etoposide—sarcoma	0.00193	0.00539	CcSEcCtD
Repaglinide—Erythema—Mitoxantrone—sarcoma	0.00192	0.00535	CcSEcCtD
Repaglinide—Hypertension—Thiotepa—sarcoma	0.00191	0.00535	CcSEcCtD
Repaglinide—Back pain—Vincristine—sarcoma	0.0019	0.00532	CcSEcCtD
Repaglinide—Arthralgia—Thiotepa—sarcoma	0.00189	0.00528	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00188	0.00524	CcSEcCtD
Repaglinide—Back pain—Mitoxantrone—sarcoma	0.00185	0.00518	CcSEcCtD
Repaglinide—ALB—lymph node—sarcoma	0.00185	0.00597	CbGeAlD
Repaglinide—Oedema—Dactinomycin—sarcoma	0.0018	0.00502	CcSEcCtD
Repaglinide—CYP2C8—testis—sarcoma	0.00179	0.00579	CbGeAlD
Repaglinide—Thrombocytopenia—Thiotepa—sarcoma	0.00177	0.00495	CcSEcCtD
Repaglinide—Leukopenia—Vincristine—sarcoma	0.00176	0.00492	CcSEcCtD
Repaglinide—Thrombocytopenia—Dactinomycin—sarcoma	0.00176	0.00492	CcSEcCtD
Repaglinide—Skin disorder—Thiotepa—sarcoma	0.00176	0.00491	CcSEcCtD
Repaglinide—Erythema multiforme—Etoposide—sarcoma	0.00173	0.00484	CcSEcCtD
Repaglinide—Leukopenia—Mitoxantrone—sarcoma	0.00171	0.00479	CcSEcCtD
Repaglinide—Eye disorder—Etoposide—sarcoma	0.00171	0.00478	CcSEcCtD
Repaglinide—Cardiac disorder—Etoposide—sarcoma	0.0017	0.00475	CcSEcCtD
Repaglinide—Hypertension—Vincristine—sarcoma	0.0017	0.00475	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—sarcoma	0.0017	0.00474	CcSEcCtD
Repaglinide—CYP2C8—liver—sarcoma	0.00169	0.00548	CbGeAlD
Repaglinide—Hypertension—Mitoxantrone—sarcoma	0.00165	0.00462	CcSEcCtD
Repaglinide—Immune system disorder—Etoposide—sarcoma	0.00165	0.00462	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00165	0.00461	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00164	0.00457	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—sarcoma	0.00164	0.00457	CcSEcCtD
Repaglinide—Arthralgia—Mitoxantrone—sarcoma	0.00163	0.00456	CcSEcCtD
Repaglinide—Chest pain—Mitoxantrone—sarcoma	0.00163	0.00456	CcSEcCtD
Repaglinide—Paraesthesia—Thiotepa—sarcoma	0.00163	0.00454	CcSEcCtD
Repaglinide—Alopecia—Etoposide—sarcoma	0.00162	0.00452	CcSEcCtD
Repaglinide—Anaphylactic shock—Vincristine—sarcoma	0.00161	0.00449	CcSEcCtD
Repaglinide—Oedema—Vincristine—sarcoma	0.00161	0.00449	CcSEcCtD
Repaglinide—Dyspepsia—Thiotepa—sarcoma	0.00159	0.00445	CcSEcCtD
Repaglinide—Thrombocytopenia—Vincristine—sarcoma	0.00157	0.00439	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—sarcoma	0.00157	0.00439	CcSEcCtD
Repaglinide—Anaphylactic shock—Mitoxantrone—sarcoma	0.00156	0.00437	CcSEcCtD
Repaglinide—Oedema—Mitoxantrone—sarcoma	0.00156	0.00437	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00156	0.00437	CcSEcCtD
Repaglinide—Constipation—Thiotepa—sarcoma	0.00155	0.00433	CcSEcCtD
Repaglinide—Back pain—Etoposide—sarcoma	0.00154	0.00431	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—sarcoma	0.00153	0.00428	CcSEcCtD
Repaglinide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00153	0.00428	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—sarcoma	0.00152	0.00425	CcSEcCtD
Repaglinide—Skin disorder—Mitoxantrone—sarcoma	0.00152	0.00424	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—sarcoma	0.00151	0.00423	CcSEcCtD
Repaglinide—Gastrointestinal pain—Thiotepa—sarcoma	0.00148	0.00414	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00147	0.00411	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00146	0.00409	CcSEcCtD
Repaglinide—Paraesthesia—Vincristine—sarcoma	0.00144	0.00403	CcSEcCtD
Repaglinide—Urticaria—Thiotepa—sarcoma	0.00144	0.00402	CcSEcCtD
Repaglinide—Abdominal pain—Thiotepa—sarcoma	0.00143	0.004	CcSEcCtD
Repaglinide—Leukopenia—Etoposide—sarcoma	0.00143	0.00399	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00142	0.00398	CcSEcCtD
Repaglinide—Abdominal pain—Dactinomycin—sarcoma	0.00142	0.00397	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00142	0.00396	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—sarcoma	0.00141	0.00393	CcSEcCtD
Repaglinide—Paraesthesia—Mitoxantrone—sarcoma	0.0014	0.00392	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vincristine—sarcoma	0.00139	0.00387	CcSEcCtD
Repaglinide—Dyspepsia—Mitoxantrone—sarcoma	0.00138	0.00385	CcSEcCtD
Repaglinide—Hypertension—Etoposide—sarcoma	0.00138	0.00384	CcSEcCtD
Repaglinide—Constipation—Vincristine—sarcoma	0.00137	0.00384	CcSEcCtD
Repaglinide—Chest pain—Etoposide—sarcoma	0.00136	0.00379	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00135	0.00376	CcSEcCtD
Repaglinide—Constipation—Mitoxantrone—sarcoma	0.00134	0.00374	CcSEcCtD
Repaglinide—Hypersensitivity—Thiotepa—sarcoma	0.00133	0.00373	CcSEcCtD
Repaglinide—Hypersensitivity—Dactinomycin—sarcoma	0.00132	0.0037	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vincristine—sarcoma	0.00131	0.00367	CcSEcCtD
Repaglinide—Anaphylactic shock—Etoposide—sarcoma	0.0013	0.00363	CcSEcCtD
Repaglinide—Pruritus—Thiotepa—sarcoma	0.00128	0.00358	CcSEcCtD
Repaglinide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00128	0.00357	CcSEcCtD
Repaglinide—Thrombocytopenia—Etoposide—sarcoma	0.00127	0.00356	CcSEcCtD
Repaglinide—Abdominal pain—Vincristine—sarcoma	0.00127	0.00355	CcSEcCtD
Repaglinide—Skin disorder—Etoposide—sarcoma	0.00126	0.00353	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—sarcoma	0.00126	0.00351	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—sarcoma	0.00125	0.00349	CcSEcCtD
Repaglinide—Urticaria—Mitoxantrone—sarcoma	0.00124	0.00347	CcSEcCtD
Repaglinide—Diarrhoea—Thiotepa—sarcoma	0.00124	0.00346	CcSEcCtD
Repaglinide—Abdominal pain—Mitoxantrone—sarcoma	0.00124	0.00345	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—sarcoma	0.00123	0.00344	CcSEcCtD
Repaglinide—Diarrhoea—Dactinomycin—sarcoma	0.00123	0.00344	CcSEcCtD
Repaglinide—Hypersensitivity—Vincristine—sarcoma	0.00118	0.0033	CcSEcCtD
Repaglinide—Paraesthesia—Etoposide—sarcoma	0.00117	0.00326	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—sarcoma	0.00116	0.00325	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—sarcoma	0.00116	0.00323	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—sarcoma	0.00116	0.00323	CcSEcCtD
Repaglinide—Hypersensitivity—Mitoxantrone—sarcoma	0.00115	0.00322	CcSEcCtD
Repaglinide—Vomiting—Thiotepa—sarcoma	0.00115	0.00322	CcSEcCtD
Repaglinide—CYP3A4—liver—sarcoma	0.00115	0.00371	CbGeAlD
Repaglinide—Vomiting—Dactinomycin—sarcoma	0.00114	0.00319	CcSEcCtD
Repaglinide—Rash—Thiotepa—sarcoma	0.00114	0.00319	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—sarcoma	0.00114	0.00319	CcSEcCtD
Repaglinide—Dermatitis—Thiotepa—sarcoma	0.00114	0.00319	CcSEcCtD
Repaglinide—Headache—Thiotepa—sarcoma	0.00113	0.00317	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00113	0.00317	CcSEcCtD
Repaglinide—Rash—Dactinomycin—sarcoma	0.00113	0.00317	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Etoposide—sarcoma	0.00112	0.00314	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—sarcoma	0.00111	0.00311	CcSEcCtD
Repaglinide—Constipation—Etoposide—sarcoma	0.00111	0.00311	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—sarcoma	0.00111	0.0031	CcSEcCtD
Repaglinide—Diarrhoea—Vincristine—sarcoma	0.0011	0.00307	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—sarcoma	0.00108	0.00302	CcSEcCtD
Repaglinide—Nausea—Thiotepa—sarcoma	0.00108	0.003	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—sarcoma	0.00107	0.003	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—sarcoma	0.00107	0.00299	CcSEcCtD
Repaglinide—Diarrhoea—Mitoxantrone—sarcoma	0.00107	0.00299	CcSEcCtD
Repaglinide—Nausea—Dactinomycin—sarcoma	0.00107	0.00298	CcSEcCtD
Repaglinide—Gastrointestinal pain—Etoposide—sarcoma	0.00106	0.00297	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00105	0.00293	CcSEcCtD
Repaglinide—Urticaria—Etoposide—sarcoma	0.00103	0.00289	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—sarcoma	0.00103	0.00288	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—sarcoma	0.00103	0.00287	CcSEcCtD
Repaglinide—Abdominal pain—Etoposide—sarcoma	0.00103	0.00287	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—sarcoma	0.00103	0.00287	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—sarcoma	0.00103	0.00287	CcSEcCtD
Repaglinide—Vomiting—Vincristine—sarcoma	0.00102	0.00285	CcSEcCtD
Repaglinide—Rash—Vincristine—sarcoma	0.00101	0.00283	CcSEcCtD
Repaglinide—Dermatitis—Vincristine—sarcoma	0.00101	0.00283	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—sarcoma	0.00101	0.00282	CcSEcCtD
Repaglinide—Headache—Vincristine—sarcoma	0.00101	0.00281	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—sarcoma	0.001	0.00279	CcSEcCtD
Repaglinide—Vomiting—Mitoxantrone—sarcoma	0.000994	0.00278	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—sarcoma	0.000992	0.00277	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—sarcoma	0.000989	0.00276	CcSEcCtD
Repaglinide—Rash—Mitoxantrone—sarcoma	0.000986	0.00275	CcSEcCtD
Repaglinide—Dermatitis—Mitoxantrone—sarcoma	0.000985	0.00275	CcSEcCtD
Repaglinide—Headache—Mitoxantrone—sarcoma	0.000979	0.00274	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—sarcoma	0.00097	0.00271	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—sarcoma	0.000959	0.00268	CcSEcCtD
Repaglinide—Hypersensitivity—Etoposide—sarcoma	0.000958	0.00268	CcSEcCtD
Repaglinide—Nausea—Vincristine—sarcoma	0.000953	0.00266	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—sarcoma	0.000952	0.00266	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—sarcoma	0.000952	0.00266	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—sarcoma	0.000949	0.00265	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—sarcoma	0.000935	0.00261	CcSEcCtD
Repaglinide—Nausea—Mitoxantrone—sarcoma	0.000929	0.00259	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—sarcoma	0.000927	0.00259	CcSEcCtD
Repaglinide—Pruritus—Etoposide—sarcoma	0.00092	0.00257	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—sarcoma	0.000916	0.00256	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—sarcoma	0.000915	0.00256	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—sarcoma	0.000907	0.00253	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—sarcoma	0.000898	0.00251	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—sarcoma	0.000893	0.0025	CcSEcCtD
Repaglinide—Erythema—Epirubicin—sarcoma	0.000893	0.0025	CcSEcCtD
Repaglinide—Diarrhoea—Etoposide—sarcoma	0.00089	0.00249	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—sarcoma	0.000887	0.00248	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—sarcoma	0.000881	0.00246	CcSEcCtD
Repaglinide—Back pain—Epirubicin—sarcoma	0.000864	0.00241	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—sarcoma	0.000857	0.0024	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—sarcoma	0.000848	0.00237	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—sarcoma	0.000839	0.00234	CcSEcCtD
Repaglinide—Vomiting—Etoposide—sarcoma	0.000827	0.00231	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—sarcoma	0.000826	0.00231	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—sarcoma	0.000826	0.00231	CcSEcCtD
Repaglinide—Rash—Etoposide—sarcoma	0.00082	0.00229	CcSEcCtD
Repaglinide—Dermatitis—Etoposide—sarcoma	0.000819	0.00229	CcSEcCtD
Repaglinide—Headache—Etoposide—sarcoma	0.000815	0.00228	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—sarcoma	0.000799	0.00223	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—sarcoma	0.000799	0.00223	CcSEcCtD
Repaglinide—Palpitations—Epirubicin—sarcoma	0.000789	0.00221	CcSEcCtD
Repaglinide—Nausea—Etoposide—sarcoma	0.000772	0.00216	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—sarcoma	0.000771	0.00215	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—sarcoma	0.00076	0.00212	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—sarcoma	0.00076	0.00212	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000755	0.00211	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—sarcoma	0.00074	0.00207	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—sarcoma	0.00073	0.00204	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—sarcoma	0.000729	0.00204	CcSEcCtD
Repaglinide—Oedema—Epirubicin—sarcoma	0.000729	0.00204	CcSEcCtD
Repaglinide—Thrombocytopenia—Epirubicin—sarcoma	0.000714	0.00199	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—sarcoma	0.000713	0.00199	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—sarcoma	0.000708	0.00198	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—sarcoma	0.000703	0.00197	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—sarcoma	0.000703	0.00197	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000699	0.00195	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—sarcoma	0.000674	0.00188	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—sarcoma	0.000674	0.00188	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000664	0.00186	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—sarcoma	0.00066	0.00185	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—sarcoma	0.000655	0.00183	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—sarcoma	0.000654	0.00183	CcSEcCtD
Repaglinide—Dyspepsia—Epirubicin—sarcoma	0.000642	0.00179	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000629	0.00176	CcSEcCtD
Repaglinide—Constipation—Epirubicin—sarcoma	0.000623	0.00174	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000614	0.00172	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—sarcoma	0.000606	0.00169	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—sarcoma	0.000596	0.00167	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—sarcoma	0.000594	0.00166	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000582	0.00163	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—sarcoma	0.000579	0.00162	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—sarcoma	0.000577	0.00161	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—sarcoma	0.000576	0.00161	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000551	0.00154	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—sarcoma	0.000537	0.0015	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—sarcoma	0.000536	0.0015	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—sarcoma	0.000533	0.00149	CcSEcCtD
Repaglinide—Pruritus—Epirubicin—sarcoma	0.000516	0.00144	CcSEcCtD
Repaglinide—Diarrhoea—Epirubicin—sarcoma	0.000499	0.00139	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—sarcoma	0.000497	0.00139	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—sarcoma	0.000477	0.00133	CcSEcCtD
Repaglinide—Vomiting—Epirubicin—sarcoma	0.000463	0.0013	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—sarcoma	0.000461	0.00129	CcSEcCtD
Repaglinide—Rash—Epirubicin—sarcoma	0.00046	0.00128	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—sarcoma	0.000459	0.00128	CcSEcCtD
Repaglinide—Headache—Epirubicin—sarcoma	0.000457	0.00128	CcSEcCtD
Repaglinide—Nausea—Epirubicin—sarcoma	0.000433	0.00121	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—sarcoma	0.000429	0.0012	CcSEcCtD
Repaglinide—Rash—Doxorubicin—sarcoma	0.000425	0.00119	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—sarcoma	0.000425	0.00119	CcSEcCtD
Repaglinide—Headache—Doxorubicin—sarcoma	0.000422	0.00118	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—sarcoma	0.000401	0.00112	CcSEcCtD
